STOCK TITAN

P3 Health Partners Inc - PIII STOCK NEWS

Welcome to our dedicated news page for P3 Health Partners (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 Health Partners.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect P3 Health Partners's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of P3 Health Partners's position in the market.

Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024, at 1:30 pm Eastern Time. Webcast available on P3's Investor Relations Website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (PIII) reports a 21% year-over-year revenue growth, exceeding 2023 guidance, with affirmations for 2024. The company anticipates achieving Adjusted EBITDA positive in 2024. Financial results for Q4 2023 show strong performance with total revenue up by 34% and capitated revenue up by 35%. Full-year 2023 results indicate total revenue growth of 21% compared to the previous year, with positive increases in key financial metrics. Despite a net loss, P3 remains optimistic about future growth prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.08%
Tags
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) plans to release its financial results for Q4 and full year 2023 on March 28, 2024, reaffirming its 2024 guidance. The company observed stable utilization trends early in 2024, with strong membership growth and plans to source additional debt capital for growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
44.33%
Tags
conferences earnings
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) announces leadership presentation at KeyBanc LifeSciences & Medtech Investor Forum. Webcast available on Investor Relations Website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to participate in Jefferies Value Based Healthcare Summit in Miami Beach, Florida. Investor meetings scheduled for March 11th, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.67%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) is set to present at the TD Cowen 44th Annual Health Care Conference in Boston. The management will conduct a webcast of the fireside chat, available on P3's Investor Relations Website. The presentation is scheduled for Monday, March 4, 2024, at 10:30 am Eastern Time, with a replay accessible for 30 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) will participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah. The company's management will host investor meetings on February 13th and 14th, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) reaffirms guidance for 2023 and announces guidance for 2024 at J.P. Morgan’s 42nd Annual Healthcare Conference. The company expects to achieve meaningful profitability in 2024, with a robust pipeline of strategic partnerships driving growth and momentum across key performance metrics. Dr. Sherif Abdou, co-founder and CEO, and Atul Kavthekar, CFO, are scheduled to present on January 10, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to present at J.P. Morgan Healthcare Conference on January 10, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
conferences
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to participate in BTIG Digital Health Forum with Dr. Sherif Abdou, CEO and Co-founder, on November 20, 2023. The forum will include a panel discussion at 12:00 p.m. PT/3:00 p.m. ET. P3 is a patient-centered and physician-led population health management company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.54%
Tags
conferences
P3 Health Partners Inc

Nasdaq:PIII

PIII Rankings

PIII Stock Data

300.73M
40.30M
26.16%
18.22%
1.8%
Dental Laboratories
Manufacturing
Link
US
Henderson

About PIII

p3 health partners (p3) is a patient-centered, physician-led and population health-focused healthcare company. founded and led by physicians, sherif abdou, and amir bacchus, p3 is a team of doctors, clinicians and support service professionals with a shared passion and purpose for improving the way patient care is delivered. we are on a mission to change the way healthcare is delivered. we believe that together as physicians, we can heal the system, restore purpose and meaning in day-to-day operations, and infuse care and health back into healthcare.